Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 60
Filter
1.
Rev Med Interne ; 45(6): 335-342, 2024 Jun.
Article in French | MEDLINE | ID: mdl-38216390

ABSTRACT

INTRODUCTION: The management of giant cell arteritis (GCA) has evolved with the arrival of tocilizumab (TCZ) and the use of PET/CT. Our objective is to describe the characteristics and followup of patients with recent diagnosis of GCA in current care. PATIENTS AND METHODS: The NEWTON cohort is a monocentric retrospective cohort based on data collected from 60 GCA patients diagnosed between 2017 and 2022 according to the ACR/EULAR 2022 criteria. RESULTS: The median age at diagnosis was 73 [68.75; 81] years old. At diagnosis, the main manifestations were unusual temporal headaches in 48 (80 %) and an inflammatory syndrome in 50 (83 %) patients. Temporal artery biopsy confirmed the diagnosis in 49/58 (84 %) patients. Doppler of the temporal arteries found a halo in 12/23 (52 %) patients. The PET/CT found hypermetabolism in 19/43 (44 %) patients. Prednisone was stopped in 17.5 [12.75; 24.25] months. During follow-up, 22 (37 %) patients received TCZ. At least one complication of corticosteroid therapy was observed in 22 (37 %) patients. After a median follow-up of 24 [12; 42] months, 25 (42 %) patients relapsed. At the end of the follow-up, 29 (48.3 %) patients were weaned from corticosteroid therapy and 15 (25 %) were on TCZ. CONCLUSION: Despite the increasing use of TCZ in the therapeutic arsenal and of the PET/CT in the imaging tools of GCA patients, relapses and complications of corticosteroid therapy remain frequent, observed in more than a third of patients.


Subject(s)
Giant Cell Arteritis , Positron Emission Tomography Computed Tomography , Humans , Giant Cell Arteritis/diagnosis , Giant Cell Arteritis/epidemiology , Giant Cell Arteritis/complications , Female , Aged , Male , Retrospective Studies , Follow-Up Studies , Aged, 80 and over , Positron Emission Tomography Computed Tomography/methods , Antibodies, Monoclonal, Humanized/therapeutic use , Cohort Studies , Temporal Arteries/pathology
2.
Eur Rev Med Pharmacol Sci ; 27(5): 1767-1773, 2023 03.
Article in English | MEDLINE | ID: mdl-36930492

ABSTRACT

BACKGROUND: Primary hypokalemic periodic paralysis (HypoPP), a rare skeletal muscle channelopathy resulting in episodic muscle weakness or paralysis under hypokalemic conditions, is caused by autosomal-dominant genetic mutations. HypoPP limits physical activity, and cardiac arrhythmias during paralytic attacks have been reported. We describe a rare familial HypoPP case complicated by sinus arrest and syncope requiring urgent temporary pacemaker implantation. CASE REPORT: A 27-year-old Vietnamese man with a family history of periodic paralysis presented with his third attack of muscle weakness triggered by intense football training the previous day. Clinical and laboratory features justified a HypoPP diagnosis. During intravenous potassium replacement, the patient experienced syncopal sinus arrest requiring urgent temporary pacemaker implantation. The patient gradually improved, responding favorably to oral potassium supplements. Genetic testing revealed an Arg1132Gln mutation in the sodium ion channel (SCN4A, chromosome 17: 63947091). At discharge, the patient received expert consultation regarding nonpharmacological preventive strategies, including avoidance of vigorous exercise and carbohydrate-rich diet. CONCLUSIONS: No evidence has established a relationship between hypokalemia and sinus arrest, and no specific treatment exists for familial HypoPP due to SCN4A mutation. Clinician awareness of this rare condition will promote appropriate diagnostic approaches and management strategies for acute paralytic attacks. Treatment should be tailored according to HypoPP phenotypes and genotypes.


Subject(s)
Hypokalemia , Hypokalemic Periodic Paralysis , Humans , Hypokalemic Periodic Paralysis/diagnosis , Hypokalemic Periodic Paralysis/genetics , NAV1.4 Voltage-Gated Sodium Channel/genetics , Mutation , Potassium , Muscle Weakness
3.
J Eur Acad Dermatol Venereol ; 36(8): 1359-1366, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35412677

ABSTRACT

BACKGROUND: Cutaneous neurofibromas (cNF), present in 95% of individuals with neurofibromatosis 1 (NF1), are considered as one of the greatest medical burden because of physical disfigurement. No specific score evaluates their impact on quality of life (QoL). OBJECTIVE: To develop a specific score assessing cNF-related QoL. METHODS: Through a multidisciplinary workshop including 10 patients, 3 expert-in-NF1 physicians, 3 health care workers (nurses and psychologist) and 1 methodologist, the French version of the Skindex-16 was modified by adding 3 items. The new cNF-Skindex was validated among patients with NF1 recruited in the ComPaRe online cohort, in France (N = 284). Construct validity was assessed by comparing it with the EQ-5D-5L, its visual analogue scale and the MYMOP2 and by assessing its association with patients' characteristics. Reliability was assessed by a test-retest. An English version of the tool was developed using a back-forward translation. RESULTS: A total of 228 individuals with NF1, with cNF answered the 19-item questionnaire. These items fitted into 3 domains: emotions, symptoms, functioning. One was dropped during analysis because >90% responders were not concerned. The cNF-Skindex significantly correlated with the EQ-5D-5L (N = 193) and MYMOP2 (N = 210) indicating good external validity: rs 0.38 (P < 0.001), and 0.58 (P < 0.001), respectively. Having >50 cNF was the only independent variable associated with the total score cNF-Skindex (ß = 15.88, 95%CI 6.96-24.81, P = 0.001), and with the 3 sub-scores: 'functioning' (ß = 2.65, 95%CI 0.71-4.59, P = 0.008), 'emotions' (ß = 17.03, 95%CI 4.11-29.96, P = 0.010) and 'symptoms' (ß = 3.90, 95%CI 1.95-5.85, P < 0.001). Test-retest reliability (N = 133) found an ICC at 0.96 demonstrating good reproducibility. CONCLUSION: The cNF-Skindex demonstrated excellent psychometric properties. The global and sub-scores were increased with higher number of cNF arguing for its use in further trials aiming to reduce their number or prevent their development. Cross-cultural validation and evaluation of its responsiveness are the next steps.


Subject(s)
Neurofibroma , Neurofibromatosis 1 , Skin Neoplasms , Adult , Humans , Neurofibromatosis 1/psychology , Psychometrics , Quality of Life/psychology , Reproducibility of Results , Surveys and Questionnaires , Translations
4.
J Eur Acad Dermatol Venereol ; 36(2): 279-285, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34657353

ABSTRACT

BACKGROUND: Vitiligo management is challenging and requires long-term adherence of patients who often complain of the burden associated with treatment. OBJECTIVE: To develop and validate a patient reported measurement of the burden of treatment in vitiligo. METHODS: The study was nested within the ComPaRe Vitiligo e-cohort, an online e-cohort of vitiligo patients in France. Items were derived from a literature review and from the qualitative analysis of a survey using open-ended questions of 204 patients with Vitiligo. Construct validity of the resulting instrument was assessed by comparing the instrument's score to the Dermatology Life Quality Index (DLQI), Vitiligo Impact Patient score (VIPs) and Treatment Burden Questionnaire (TBQ) scores. Reliability was assessed by test-retest with 15 ± 10 days of interval between both assessments. RESULTS: In total, 343 adult participants participated in the validation of the Vitiligo Treatment Impact score (VITs). The VITs is a 19-item questionnaire assessing the burden of treatment in patients with vitiligo with results suggesting four domains ('Finding a doctor', 'Phototherapy', 'Topical treatment' and 'Impact on outdoor activities and photoprotection'). The VITs total score was well correlated with the DLQI, VIP and TBQ scores. Agreement between test and retest was good (ICC 0.705, 95% CI 0.491-0.818). CONCLUSIONS: We developed a patient reported measurement of the burden of treatment in vitiligo with good psychometric properties.


Subject(s)
Vitiligo , Adult , Cohort Studies , Humans , Psychometrics , Quality of Life , Reproducibility of Results , Surveys and Questionnaires , Vitiligo/therapy
5.
Br J Dermatol ; 185(4): 787-796, 2021 10.
Article in English | MEDLINE | ID: mdl-33830502

ABSTRACT

BACKGROUND: Shared decision-making tools (SDMt) are visual tools developed to promote joint medical decisions between physicians and patients. There is a paucity of such tools in dermatology. OBJECTIVES: To develop and validate a SDMt for use in specialized consultation for vitiligo. METHODS: A prospective cross-sectional study was carried out from March 2019 to March 2020. We first conducted a qualitative study of topics discussed by patients and clinicians during therapeutic decision-making in the setting of a specialized consultation for vitiligo using an anchored-theory method, which allowed conceptualization of the SDMt. The usefulness of the SDMt was evaluated by a working group of multidisciplinary health workers and patients with vitiligo. Consensus on the final tool was obtained through an e-Delphi method. RESULTS: We recruited 30 patients with vitiligo for the qualitative study, which identified 91 topics related to therapeutic decision-making. Hierarchical clustering analysis confirmed the distribution of these topics in two subgroups (general treatment goals and priorities, and topics specific to each treatment). The consensus of a multidisciplinary group was used to develop the SDMt. The tool was comprised of eight A5 cards, which addressed face repigmentation; body repigmentation (limited area); body repigmentation (extended area); partial or complete depigmentation; coping with the disease; stabilization of disease; maintaining repigmentation; and disease information. Cognitive interviews confirmed the satisfaction, readability and usefulness of the SDMt. The SDMt was then translated and culturally validated in English. CONCLUSIONS: We developed a tool for shared decision-making in nonsegmental vitiligo, which we translated and cross-culturally validated in a US patient population with vitiligo to ensure its generalizability.


Subject(s)
Vitiligo , Cross-Sectional Studies , Face , Humans , Prospective Studies , Skin Pigmentation , Treatment Outcome , Vitiligo/therapy
6.
Rev Sci Instrum ; 91(4): 043505, 2020 Apr 01.
Article in English | MEDLINE | ID: mdl-32357761

ABSTRACT

We describe a plasma-cathode electron beam source based on a hollow cathode glow discharge and operating in the forevacuum pressure range that produces a steady-state ribbon beam. The electron beam is generated in the pressure range of 10-30 Pa. A multi-aperture electron extraction and beam formation system is used to provide beam stability and enhanced uniformity of beam current density, allowing the use of this kind of device for beam-plasma surface modification over relatively large areas.

8.
Public Health ; 181: 65-72, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31954871

ABSTRACT

OBJECTIVES: To document the prevalence of overweight and obesity and examine associated risk factors. STUDY DESIGN: A cross-sectional survey was conducted in 16 primary public schools in eight districts of Ho Chi Minh City in 2016. A multistage clustering sampling method was used to collect a sample of 1806 pupils attending the first, second, and third grades (7-9 years). METHODS: Age- and sex-adjusted body mass index (BMI) status was defined using International Obesity Taskforce cut-offs. Ordered probit regression models were used to assess the association between child BMI and its socio-economic and demographic risk factors. The model was estimated separately for boys and girls to assess the extent to which the socio-economic gradients in BMI vary by gender. RESULTS: The prevalence of obesity among boys was twice the rate for girls (24.7 vs 12.3%). The prevalence of overweight and obesity were also higher among pupils attending schools located in urban districts than in semi-rural districts. Gender, household wealth, the frequency of having breakfast at home, parental body weight, and school location were strong predictors of child BMI status. The protective effect of having breakfast more frequently at home against the risk of overweight/obesity was more pronounced in girls than in boys. Father's body weight and child BMI were more strongly associated with boys from poorer households than boys from wealthier households, while the differences were not significant for girls. CONCLUSIONS: The high prevalence of childhood overweight and obesity indicates an urgent need for more gender-specific, effective intervention, and prevention programs.


Subject(s)
Body Mass Index , Obesity/epidemiology , Pediatric Obesity/epidemiology , Adolescent , Body Weight , Child , Cross-Sectional Studies , Female , Humans , Male , Prevalence , Risk Factors , Rural Population , Schools , Surveys and Questionnaires , Vietnam/epidemiology
10.
ACS Appl Mater Interfaces ; 9(29): 24433-24439, 2017 Jul 26.
Article in English | MEDLINE | ID: mdl-28696665

ABSTRACT

Magnetoplasmonic Fe3O4-coated Ag nanoparticles (NPs) are assembled in large scale (18 × 18 mm2) in order to observe unique modulation of plasmonic coupling and optical tunable application via both external magnetic field and the combination of magnetic dipole and electrostatic interactions of particle-particle and particle-substrate. These large nanochains film exhibits outstanding tunability of plasmonic resonance from visible to near-infrared range by controlling the polarization angle and interparticle distance (IPD). The enormous spectral shift mainly originated from far-field rather than near-field coupling of Ag cores because of the sufficiently large separation between them in which Fe3O4 shell acts as spacer. This tunable magnetoplasmonic film can be applicable in the field of anisotropic optical waveguides, tunable optical filter, and nanoscale sensing platform.

11.
Ann Oncol ; 28(4): 688-695, 2017 04 01.
Article in English | MEDLINE | ID: mdl-28011448

ABSTRACT

Background: Protocols are often unavailable to peer-reviewers and readers. To detect outcome reporting bias (ORB), readers usually have to resort to publicly available descriptions of study design such as public clinical trial registries. We compared primary outcomes in protocols, ClinicalTrials.gov and publications of oncology trials and evaluated the use of ClinicalTrials.gov as compared with protocols in detecting discrepancies between planned and published outcomes. Method: We searched for phase III oncology trials registered in ClinicalTrials.gov and published in the Journal of Clinical Oncology and New England Journal of Medicine between January 2014 and June 2015. We extracted primary outcomes reported in the protocol, ClinicalTrials.gov and the publication. First, we assessed the quality of primary outcome descriptions by using a published framework. Second, we evaluated modifications of primary outcomes between each source. Finally, we evaluated the agreement, specificity and sensitivity of detecting modifications between planned and published outcomes by using protocols or ClinicalTrials.gov. Results: We included 65 trials, with 81 primary outcomes common among the 3 sources. The proportion of primary outcomes reporting all items from the framework was 73%, 22%, and 75% for protocols, ClinicalTrials.gov and publications, respectively. Eight (12%) trials presented a discrepancy between primary outcomes reported in the protocol and in the publication. Twelve (18.5%) trials presented a discrepancy between primary outcomes registered at ClinicalTrials.gov and in publications. We found a moderate agreement in detecting discrepant reporting of outcomes by using protocols or ClinicalTrials.gov [κ = 0.53, 95% confidence interval (0.25-0.81)]. Using ClinicalTrials.gov to detect discrepant reporting of outcomes showed high specificity (89.5%) but lacked sensitivity (75%) as compared with use of protocols. Conclusion: In oncology trials, primary outcome descriptions in ClinicalTrials.gov are often of low quality and may not reflect what is in the protocol, thus limiting the detection of modifications between planned and published outcomes.


Subject(s)
Bias , Biomedical Research/standards , Clinical Trials, Phase III as Topic/standards , Medical Oncology/standards , Research Design/standards , Humans , Registries
14.
Eur J Pharm Biopharm ; 75(2): 128-36, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20226857

ABSTRACT

Incomplete protein release from PLGA-based microspheres due to protein interactions with the polymer is one of the main issues in the development of PLGA protein-loaded microspheres. In this study, a two-dimensional adsorption model was designed to rapidly assess the anti-adsorption effect of formulation components (additives, additives blended with the polymer or modified polymers). Lysozyme was chosen as a model protein because of its strong, non-specific adsorption on the PLGA surface. This study showed that PEGs, poloxamer 188 and BSA totally inhibited protein adsorption onto the PLGA37.5/25 layer. Similarly, it was emphasised that more hydrophilic polymers were less prone to protein adsorption. The correlation between this model and the in vitro release profile was made by microencapsulating lysozyme with a low loading in the presence of these excipients by a non-denaturing s/o/w encapsulation technique. The precipitation of lysozyme with the amphiphilic poloxamer 188 prior to encapsulation exhibited continuous release of active lysozyme over 3 weeks without any burst effect. To promote lysozyme release in the latter stage of release, a PLGA-PEG-PLGA tribloc copolymer was used; lysozyme was continuously released over 45 days in a biologically active form.


Subject(s)
Drug Carriers/chemistry , Excipients/chemistry , Lactic Acid/chemistry , Muramidase/administration & dosage , Polyglycolic Acid/chemistry , Adsorption , Animals , Cattle , Chemical Precipitation , Delayed-Action Preparations , Emulsions , Microspheres , Muramidase/chemistry , Poloxamer/chemistry , Polyethylene Glycols/chemistry , Polylactic Acid-Polyglycolic Acid Copolymer , Polymers/chemistry , Serum Albumin, Bovine/chemistry , Time Factors
15.
Acta Chir Belg ; 107(5): 544-7, 2007.
Article in English | MEDLINE | ID: mdl-18074916

ABSTRACT

A 74-year-old male presented with bilateral invalidating claudication. A bilateral percutaneous transluminal angioplasty (PTA) with stenting of both superficial femoral arteries was performed but complicated by an urosepsis with Escherichia coli and a septic phlebitis at the site of an intravenous line. The phlebitis was complicated by a local abcedation for which incision and drainage were performed. One month after discharge he was readmitted at our hospital with septic fever and positive hemocultures for Escherichia coli. Positron emission tomography-computed tomographic scan (PET/CT-scan) showed a mycotic aneurysm of the thoracic aorta. Because no cryopreserved donor aorta was available and the aneurysm size rapidly increased, an open in situ repair was performed with a Dacron silver prosthesis soaked in rifampicin. His recovery was further complicated by a perforated toxic megacolon for which a subtotal colectomy was performed. Further recovery was uncomplicated and 10 months after the aortic repair patient is still free from infection.


Subject(s)
Aneurysm, Infected/surgery , Aortic Aneurysm, Thoracic/surgery , Aged , Aneurysm, Infected/epidemiology , Aortic Aneurysm, Thoracic/epidemiology , Blood Vessel Prosthesis Implantation , Colectomy , Comorbidity , Humans , Intermittent Claudication/epidemiology , Intermittent Claudication/etiology , Male , Megacolon, Toxic/epidemiology , Megacolon, Toxic/surgery
16.
Klin Monbl Augenheilkd ; 221(5): 351-6, 2004 May.
Article in English | MEDLINE | ID: mdl-15162278

ABSTRACT

BACKGROUND: Birdshot chorioretinopathy is characterised by dual unrelated inflammatory involvement of the retina and the choroid. Indocyanine green angiography made it possible to assess and follow choroidal disease with the same precision as retinal involvement was followed so far. The aim of this study was to analyse the severity, progression and response to therapy of both retinal involvement using fluorescein angiography and choroidal involvement using indocyanine green angiography. PATIENTS AND METHODS: Patients with birdshot retinochoroidopathy followed at La Source Eye Centre in Lausanne, Switzerland from January 1995 to December 2002 were subdivided into three subgroups according to the duration of evolution of the disease: untreated patients with no more than one year duration of the disease (group 1, n = 6); treated patients with disease duration of 1 - 7 years duration (group 2, n = 5) and patients with disease lasting for more than 7 years (group 3, n = 4). Fluorescein and indocyanine green angiographic signs (angiographic scores given by a masked observer) were analysed in the 3 groups and compared to the "cream-coloured" fundus lesions. RESULTS: Fifteen out of the 742 patients (2.0 %) seen at La Source Eye Centre during the time period considered presented BC and were included in the study. In the "early disease group" fluorescein and ICG angiography showed more severe choroidal than retinal involvement with respective scores of 3 +/- 0.79 (ICG) and 2 +/- 1.17 (FA) while there were few depigmented fundus lesions to be seen (score 1 +/- 0.27). The choroidal involvement responded well to systemic corticosteroids +/- immunosuppressive therapy (scores in groups 2 and 3 = 1.2 and 0.75), while retinal disease was stabilised at best (scores in groups 2 and 3 = 2.2. and 2.4) and depigmented fundus lesions increased (scores in groups 2 and 3 = 2.8 and 3). CONCLUSION: The evolution and response to therapy of retinal and choroidal disease in birdshot chorioretinopathy have a different course with choroidal disease responding well to therapy while retinal disease is more resistant, possibly explaining the slow deterioration of functional parameters despite therapy. The increase of "cream-coloured" fundus lesions despite good choroidal response to therapy could be explained by depigmentation left behind after resolution of choroidal stromal granulomas, a hypothesis recently confirmed by an autopsy case of birdshot chorioretinopathy.


Subject(s)
Chorioretinitis/diagnosis , Fluorescein Angiography , Adrenal Cortex Hormones/therapeutic use , Adult , Chorioretinitis/classification , Chorioretinitis/drug therapy , Disease Progression , Female , Fluorescein , Follow-Up Studies , Humans , Immunosuppressive Agents/therapeutic use , Indocyanine Green , Male , Middle Aged , Treatment Outcome , Visual Fields/drug effects , Visual Fields/physiology
17.
Cell ; 107(6): 801-13, 2001 Dec 14.
Article in English | MEDLINE | ID: mdl-11747815

ABSTRACT

KChIP2, a gene encoding three auxiliary subunits of Kv4.2 and Kv4.3, is preferentially expressed in the adult heart, and its expression is downregulated in cardiac hypertrophy. Mice deficient for KChIP2 exhibit normal cardiac structure and function but display a prolonged elevation in the ST segment on the electrocardiogram. The KChIP2(-/-) mice are highly susceptible to the induction of cardiac arrhythmias. Single-cell analysis revealed a substrate for arrhythmogenesis, including a complete absence of transient outward potassium current, I(to), and a marked increase in action potential duration. These studies demonstrate that a defect in KChIP2 is sufficient to confer a marked genetic susceptibility to arrhythmias, establishing a novel genetic pathway for ventricular tachycardia via a loss of the transmural gradient of I(to).


Subject(s)
Calcium-Binding Proteins/genetics , Genetic Predisposition to Disease , Myocardium/metabolism , Potassium Channels, Voltage-Gated , Potassium/metabolism , Tachycardia, Ventricular/genetics , Action Potentials/physiology , Alternative Splicing , Amino Acid Sequence , Animals , Base Sequence , Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/metabolism , Electrocardiography , Embryo, Mammalian/metabolism , Gene Targeting , Humans , In Situ Hybridization , Kv Channel-Interacting Proteins , Membrane Potentials/physiology , Mice , Mice, Knockout , Models, Biological , Molecular Sequence Data , Myocardium/cytology , Patch-Clamp Techniques , Potassium Channels/genetics , Potassium Channels/metabolism , Protein Isoforms , Shal Potassium Channels , Tachycardia, Ventricular/etiology , Tachycardia, Ventricular/physiopathology
18.
Eye (Lond) ; 15(Pt 1): 23-30, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11318288

ABSTRACT

PURPOSE: To determine the use of high-frequency ultrasound biomicroscopy (UBM) in the assessment of inflammatory lesions of the iris, ciliary body, pars plana and peripheral vitreous, and in particular to determine the proportion of cases for which UBM contributed significant additional, hitherto inaccessible, information. METHODS: Charts of patients seen in the uveitis clinic at University Eye Hospital from November 1994 to September 1999 for whom a UBM investigation had been performed were analysed. UBM was performed in a standard manner, using a Humphrey UBM 840 system. The clinical relevance of the UBM findings was determined for the whole series and for the following six subgroups of patients arbitrarily established according to the type and location of pathology: hypotony, pseudophakic uveitis, iris and ciliary body pathology excluding hypotony, pars plana pathology, scleritis and Toxocara uveitis. Findings were classified as positive when they confirmed a suspected diagnosis of lesional process or when they gave essential information. Findings were classified as essential when they led to the diagnosis or when they modified therapeutic intervention. RESULTS: During the study period 111 eyes of 77 patients were included. UBM findings contributed essential information that allowed a diagnosis to be reached or that influenced treatment in 43% of cases. It yielded positive findings in 91% of cases, enabling assessment of morphological changes in the iris, ciliary body, and retroiridal and peripheral vitreous induced by intraocular inflammatory or pseudo-inflammatory disorders. Specific UBM signs, present in all patients, were identified in Toxocara uveitis. The groups of patients that benefited most from UBM examination were those with hypotony (83% essential findings) and opaque media (100% essential findings). CONCLUSION: For uveitis patients with an inflammatory process situated in the iris/ciliary body/pars plana/retroiridal vitreous areas, UBM was of great clinical value and improved the management in a significant manner.


Subject(s)
Uveitis/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Eye Infections, Parasitic/diagnostic imaging , Female , Humans , Male , Microscopy/methods , Middle Aged , Ocular Hypotension/diagnostic imaging , Pars Planitis/diagnostic imaging , Sarcoidosis/diagnostic imaging , Toxocariasis/diagnostic imaging , Ultrasonography , Uveitis, Anterior/diagnostic imaging
19.
BJU Int ; 86(9): 989-92, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11119090

ABSTRACT

OBJECTIVE: To determine whether the addition of ethanol to water for irrigation during transurethral resection of the prostate (TURP) and monitoring breath ethanol could be used to detect irrigant absorption and to limit free plasma haemoglobin in cases of absorption. PATIENTS AND METHODS: One hundred patients (46 in Piteå, Sweden and 54 in Uong bi, Vietnam) underwent surgery for benign prostatic hyperplasia (BPH) under an intermittent irrigation technique using water containing 2% ethanol. An expired breath alcohol meter was used to monitor ethanol in the patients' breath every 5 min. Blood samples taken after TURP were assessed for free haemoglobin in 99 patients, and other markers of haemolysis were also evaluated in the Swedish group. RESULTS: Thirty-two patients had detectable ethanol in their breath. There was a close correlation between the maximum ethanol reading during surgery and the level of free plasma haemoglobin after TURP (r = 0.90, P < 0.001). There was no correlation between the duration of TURP and the free haemoglobin level. CONCLUSION: Monitoring breath ethanol during TURP assesses absorption and so can help to keep control of haemolysis. It is suggested that the value on the alcohol meter should not be allowed to exceed 0.15 (corresponding to a blood ethanol level of 0.15 per thousand), which should maintain the free plasma haemoglobin level at < 1.0 g/L after TURP. Restricting the operative duration per se is not a reliable safety measure.


Subject(s)
Hemolysis/physiology , Prostatic Hyperplasia/surgery , Transurethral Resection of Prostate/adverse effects , Water , Absorption , Aged , Breath Tests , Ethanol , Humans , Male , Prostatic Hyperplasia/blood , Therapeutic Irrigation/methods
20.
Cell ; 102(5): 671-82, 2000 Sep 01.
Article in English | MEDLINE | ID: mdl-11007485

ABSTRACT

HF-1 b, an SP1 -related transcription factor, is preferentially expressed in the cardiac conduction system and ventricular myocytes in the heart. Mice deficient for HF-1 b survive to term and exhibit normal cardiac structure and function but display sudden cardiac death and a complete penetrance of conduction system defects, including spontaneous ventricular tachycardia and a high incidence of AV block. Continuous electrocardiographic recordings clearly documented cardiac arrhythmogenesis as the cause of death. Single-cell analysis revealed an anatomic substrate for arrhythmogenesis, including a decrease and mislocalization of connexins and a marked increase in action potential heterogeneity. Two independent markers reveal defects in the formation of ventricular Purkinje fibers. These studies identify a novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages.


Subject(s)
DNA-Binding Proteins/physiology , Death, Sudden, Cardiac/pathology , Gene Deletion , Heart Conduction System/pathology , Heart Conduction System/physiopathology , Heart Ventricles/pathology , Potassium Channels, Voltage-Gated , Action Potentials , Alleles , Animals , Cell Count , Cell Lineage , Connexins/analysis , DNA-Binding Proteins/analysis , DNA-Binding Proteins/genetics , Electric Conductivity , Electrocardiography , Female , Heart Block/metabolism , Heart Block/pathology , Heart Block/physiopathology , Heart Conduction System/metabolism , Heart Ventricles/embryology , Heart Ventricles/metabolism , Heart Ventricles/physiopathology , Male , Mice , Mice, Knockout , Penetrance , Potassium/metabolism , Potassium Channels/analysis , Potassium Channels/metabolism , Purkinje Fibers/metabolism , Purkinje Fibers/pathology , Purkinje Fibers/physiopathology , RNA, Messenger/analysis , RNA, Messenger/genetics , Radio , Sp4 Transcription Factor , Tachycardia, Ventricular/metabolism , Tachycardia, Ventricular/pathology , Tachycardia, Ventricular/physiopathology , Telemetry , Gap Junction alpha-5 Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...